Pazopanib-d6
CAS: 1219592-01-4
Rif. 3D-UYB59201
1mg | Fuori produzione | ||
5mg | Fuori produzione | ||
10mg | Fuori produzione | ||
25mg | Fuori produzione | ||
50mg | Fuori produzione |
Informazioni sul prodotto
Pazopanib-d6 is a drug that binds to the ATP binding site on the enzyme tyrosine kinase, which is involved in cellular growth, differentiation, and survival. It inhibits the kinase activity of tyrosine kinases and prevents cell proliferation, differentiation, and survival. Pazopanib-d6 has been shown to be effective against human cancers such as renal cell carcinoma (RCC) and colorectal cancer. The selectivity of this drug for cancer cells has been demonstrated using a high performance liquid chromatography (HPLC) method with an electrospray ionization source. The sensitivity of this assay is approximately 1 ng/mL.